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Abstract: The carnitine/organic cation transporter novel 2 (OCTN2) is responsible for the cellular uptake
of carnitine in most tissues. Being a transmembrane protein OCTN2 must interact with the surrounding
lipid microenvironment to function. Among the main lipid species that constitute eukaryotic cells, choles-
terol has highly dynamic levels under a number of physiopathological conditions. This work describes how
plasma membrane cholesterol modulates OCTN2 transport of L-carnitine in human embryonic kidney 293
cells overexpressing OCTN2 (OCTN2-HEK293) and in proteoliposomes harboring human OCTN2. We
manipulated the cholesterol content of intact cells, assessed by thin layer chromatography, through short
exposures to empty and/or cholesterol-saturated methyl-฀-cyclodextrin (m฀cd), whereas free cholesterol
was used to enrich reconstituted proteoliposomes. We measured OCTN2 transport using [3H]L-carnitine,
and expression levels and localization by surface biotinylation and Western blotting. A 20-min prein-
cubation with m฀cd reduced the cellular cholesterol content and inhibited L-carnitine influx by 50% in
comparison with controls. Analogously, the insertion of cholesterol in OCTN2-proteoliposomes stimu-
lated L-carnitine uptake in a dose-dependent manner. Carnitine uptake in cells incubated with empty
m฀cd and cholesterol-saturated m฀cd to preserve the cholesterol content was comparable with controls,
suggesting that the m฀cd effect on OCTN2 was cholesterol dependent. Cholesterol stimulated L-carnitine
influx in cells by markedly increasing the affinity for L-carnitine and in proteoliposomes by significantly
enhancing the affinity for Na+ and, in turn, the L-carnitine maximal transport capacity. Because of the
antilipogenic and antioxidant features of L-carnitine, the stimulatory effect of cholesterol on L-carnitine
uptake might represent a novel protective effect against lipid-induced toxicity and oxidative stress.
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The carnitine/organic cation transporter novel 2 
(OCTN2) is responsible for the cellular uptake of 
carnitine in most tissues. Being a transmembrane 
protein OCTN2 must interact with the surrounding 
lipid microenvironment to function. Among the main 
lipid species that constitutes eukaryotic cells, 
cholesterol level is highly dynamic under a number 
of physio-pathological conditions. This work 
describes how plasma membrane cholesterol 
modulates OCTN2 transport of L-carnitine in human 
embryonic kidney 293 cells overexpressing OCTN2 
(OCTN2-HEK293) and in proteoliposomes 
harboring human OCTN2. We manipulated the 
cholesterol content of intact cells, assessed by thin 
layer chromatography, through short exposures to 
empty and/or cholesterol-saturated methyl-β-
cyclodextrin (mβcd), whereas free cholesterol was 
used to enrich reconstituted proteoliposomes. We 
measured OCTN2 transport using [3H]L-carnitine, 
and expression levels and localization by surface 
biotinylation and western blotting. A 20-minute 
preincubation with mβcd reduced the cellular 
cholesterol content and inhibited L-carnitine influx 
by 50% in comparison to controls. Analogously, the 
insertion of cholesterol in OCTN2-proteoliposomes 
stimulated L-carnitine uptake in a dose-dependent 
manner. Carnitine uptake in cells incubated with 
empty mβcd and cholesterol-saturated mβcd to 
preserve cholesterol content was comparable to 
controls, suggesting that the mβcd effect on OCTN2 
was cholesterol dependent. Cholesterol stimulated L-
carnitine influx in cells by markedly increasing the 
affinity for L-carnitine and in proteoliposomes by 
significantly enhancing the affinity for Na+ and, in 
turn, the L-carnitine maximal transport capacity. 
Because of the antilipogenic and antioxidant features 
of L-carnitine, the stimulatory effect of cholesterol on 
L-carnitine uptake might represent a novel protective 





Carnitine is a vitamin-like compound cardinal in the 
translocation of mid- and long-chain fatty acids from 
the cytosol into the mitochondrial matrix, where the 
fatty acid β-oxidation takes place (1,2). An important 
experimental model for the comprehension of the role 
of carnitine in cell metabolism has been and still is 
the juvenile visceral steatosis (jvs) mouse. Jvs pups 
are characterized by systemic carnitine deficiency, 
hepatic steatosis, hypoglycaemia and 
hyperammonaemia and growth retardation (3-6). 
This phenotype closely resembles that observed in 
children and adults diagnosed with primary systemic 
carnitine deficiency (OMIM212149), a metabolic 
disorder in which the body cannot properly process 
fats to produce energy (4). Primary systemic carnitine 
deficiency in both human and rodents is caused by 
loss of function mutations in the SLC22A5/Slc22a5 
gene encoding for the carnitine/organic cation 
transporter novel 2 (OCTN2). OCTN2 is a plasma 
membrane transporter belonging to the SLC22 family 
and is responsible for the Na+-dependent transport of 
carnitine and its precursor butyrobetaine (7,8). In 
vitro, OCTN2 also mediates the uptake of a number 
of drugs (e.g. oxaliplatin, beta-lactams) (9-12). 
Experiments in jvs animals indicate that OCTN2 is 
critical for the intestinal absorption, distribution in 
liver, skeletal muscle and heart, and in renal 
reabsorption of carnitine (3-6,13-16).  
 
In line with the pivotal role of carnitine in lipid 
metabolism, OCTN2 expression level is closely 
linked to lipid homeostasis. The nuclear receptor 
PPARα, activated by free fatty acids, induces the 
mRNA expression of OCTN2 in rodents and pig (17-
22). In humans, insulin is associated with an increase 
in OCTN2 expression and activity in skeletal muscle 
(23). Overall, OCTN2 induction may represent an 
adaptive protective mechanism, thereby reducing 
lipid accumulation and toxicity in cells. Animal fed a 
high fat diet not only display elevated lipids in the 
plasma, but also in the cellular membranes of various 
organs (24-26). Because of the fine-tuned interaction 
between transmembrane proteins and the surrounding 
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lipid microenvironment, we hypothesized that the 
accumulation of lipids in the plasma membrane might 
as well promote L-carnitine uptake mediated by 
OCTN2. In particular, plasma membrane cholesterol 
has been extensively associated with transmembrane 
protein function (27-30) through lipid-lipid and/or 
protein-lipid interactions. By interacting with 
phospholipids, cholesterol alters the fluidity of the 
lipid bilayer (31-36). Cholesterol seems also to bind 
to transmembrane protein domains known as 
Cholesterol Recognition/interaction Amino acid 
Consensus sequences (CRAC and CARC) (37). The 
aim of the present work is to outline the effects of 
cholesterol on OCTN2-mediated L-carnitine 
transport employing intact cells overexpressing the 
human OCTN2 and proteoliposomes harboring the 





Effect of mβcd exposure on cholesterol content 
and L-carnitine influx in intact cells 
As previously shown, short exposure to methyl-β-
cyclodextrin (mβcd) allows selectively scavenging of 
cholesterol from cells (38). HEK293 cells stably 
transfected with the coding sequence of the human 
OCTN2 (Fig. 1A), and Human hepatocellular 
carcinoma cells (Huh-7) cells transiently transfected 
with the human OCTN2 (Fig. 1B), exposed for 20 
minutes to mβcd were characterized by a ~ 50% 
depletion of total cholesterol in comparison with the 
untreated cells. The impact of cholesterol removal on 
OCTN2 function was evaluated by assessing the L-
carnitine uptake at the non-saturating extracellular 
concentration of 0.5 µM in the presence or absence of 
Na+ over 15 seconds, an interval in which the 
transport of L-carnitine is linear, reflecting the 
unidirectional flux of the substrate into the cells (12). 
As shown in Figure 1C, the 20-minute preincubation 
with mβcd significantly reduced the Na+-dependent 
influx of L-carnitine (0.002 ± 0.001 vs 0.006 ± 0.003 
pmol/µg of protein, P=0.02) in OCTN2-HEK293 
cells. In a similar fashion, in OCTN2-Huh-7 cells, the 
mβcd pre-incubation reduced the uptake of L-
carnitine by ~50% as compared with that in untreated 
OCTN2-Huh-7 cells (0.00018 ± 0.00004 vs 0.00031 
± 0.00007 pmol/µg of protein, P=0.05). A possible 
direct inhibitory effect of mβcd on L-carnitine 
OCTN2-mediated transport was ruled out by 
measuring L-carnitine uptake in the presence of mβcd 
at the extracellular concentration of 2.5 mM in 
OCTN2-HEK293 cells. It can be seen that mβcd did 
not directly interfere with the L-carnitine-OCTN2 
interaction (0.006 ± 0.003 vs 0.007 ± 0.002 pmol/µg 
of protein, P=NS) (Fig. 1E). Because of the relatively 
low transport rate of L-carnitine measured in 
OCTN2-Huh-7 cells, thus the low signal-to-noise 
ratio, the nature of the OCTN2-cholesterol 
interaction was further investigated exclusively in 
OCTN2-HEK293 cells. The inhibitory effect of 
cholesterol depletion L-carnitine uptake mediated by 
OCTN2 was observed also in OCTN2-HEK293 cells 
exposed to atorvastatin, an inhibitor of the HMG-
CoA reductase (3-hydroxy-3-methyl-glutaryl-
coenzyme A reductase), the rate-limiting enzyme in 
cholesterol synthesis (Fig. S1).    
 
Impact of mβcd exposure on OCTN2 localization 
and lipid raft integrity  
Surface labelling coupled to Western blotting, was 
employed to assess OCTN2 expression level in 
OCTN2-HEK293 cells upon exposure to mcd. As 
shown in Figure 2A, plasma membrane OCTN2 
protein level was comparable in control and mcd-
treated cells.  
Cholesterol distribution in the membrane is 
heterogeneous, concentrating in cholesterol-rich and 
sphingomyelin-rich membrane domains (membrane 
rafts). Several studies have shown that cholesterol 
depletion results in the spatial reorganization of 
membrane proteins because of the shattering of the 
cholesterol-enriched domains (39). In addition, 
studies in rat astrocytes demonstrated that plasma 
membrane Octn2 localizes primarily in lipid rafts, 
where it directly interacts with caveolin-1, a 
membrane protein enriched in lipid rafts (40). In 
order to examine whether OCTN2 localized in 
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membrane rafts and to what extent OCTN2 
membrane localization was affected by the treatment 
with mβcd, the surface expression level of OCTN2 
was assessed in the raft (insoluble) and non-raft 
(soluble) fractions of OCTN2-HEK293 cells. Figure 
2B shows that upon cholesterol depletion, there was 
a significant disruption of the raft fraction, as shown 
by the redistribution of CAVEOLIN-1 and 
FLOTILLIN-1 from the insoluble (rafts) to the 
soluble fraction (non-rafts). Moreover, it can be seen 
that both Na+/K+ ATPase, a known non-raft marker 
(41), and OCTN2, were almost exclusively detected 
in the soluble fraction (non-rafts), suggesting that 
OCTN2 did not cluster in the lipid rafts.    
 
Impact of mβcd exposure on membrane integrity 
and membrane potential 
Plasma membrane leaking and/or the inhibition of the 
Na+/K+ ATPase might as well contribute to the 
reduced uptake of L-carnitine observed upon pre-
incubation to mβcd (7,42). To assess the plasma 
membrane integrity, OCTN2-HEK293 cells were 
exposed for 20 minutes to mβcd and then mixed with 
the Trypan blue solution for cell counting. Figure 3A 
shows that the fractions of control and mβcd-treated 
cells impermeable to Trypan blue were comparable; 
indicating that mβcd pre-incubation did not alter the 
plasma membrane integrity. The activity of the 
Na+/K+ ATPase is critical to sustain the Na+ inward 
gradient, hence to the L-carnitine OCTN2-mediated 
transport. A reduction in the Na+/K+ ATPase activity 
or an outward leaking of Na+ would result in a 
reduced Na+ inward gradient and, in turn, in 
membrane potential depolarization. As chloride 
distribution has been shown to correlate well with the 
cell membrane potential (43-46), the impact of mβcd 
preincubation on plasma membrane potential was 
assessed by monitoring the distribution of chloride 
ions across the plasma membrane. Figure 3B shows 
that, at equilibrium, the intracellular level of chloride 
ions was increased by a 20-minute exposure to 
ouabain, which inhibits the Na+/K+ ATPase, causing 
the partial depolarization of the plasma membrane 
(P=0.018). Conversely, the pre-incubation with mβcd 
slightly, albeit significantly, hyperpolarized the 
plasma membrane as reflected by the lower 
intracellular chloride ion concentration (P=0.049).   
 
Effect of exogenous cholesterol on total 
cholesterol levels and OCTN2-mediated L-
carnitine transport 
To assess whether the effect of mβcd on OCTN2-
mediated L-carnitine influx was cholesterol-
dependent, “cholesterol-matched” experiments were 
performed. It can be seen that OCTN2-HEK293 cells 
exposed for 20 minutes to varying ratios of empty 
mβcd:cholesterol-saturated mβcd (RAMEB) 
mixtures showed similar total cholesterol content to 
that of control cells (Figure 4A). The 3:1 
mβcd:RAMEB ratio was used for assessing L-
carnitine transport. OCTN2-mediated L-carnitine 
influx after pre-incubation with mβcd:RAMEB (3:1) 
was comparable to that in control cells (0.009±0.002 
vs 0.007±0.002 pmol/µg of protein, P=NS), 
indicating that the mβcd effect on OCTN2-mediated 
L-carnitine transport is cholesterol-dependent (Fig. 
4B). 
 
Effect of cholesterol incorporation on L-carnitine 
OCTN2-mediated transport in reconstituted 
proteoliposomes  
The study of the effect of cholesterol on OCTN2 
activity in intact cells was limited by the resistance of 
the OCTN2-HEK293 cells to cholesterol overloading 
(Fig. 4A) and by the deleterious effect of more 
extensive cholesterol depletion, which is likely to 
jeopardize cell viability. Hence, to better characterize 
the dependence of OCTN2 transport activity on 
cholesterol content, OCTN2 protein was extracted 
from OCTN2-HEK293 cells and reconstituted in egg 
yolk phospholipid-liposomes. Figure 5A illustrating 
the uptake of L-carnitine in presence of increasing 
concentration of Na+, demonstrates that the 
proteoliposomes harboring OCTN2 were functional. 
In line with the results obtained in intact cells, the 
transport of L-carnitine was stimulated by the 
incorporation of exogenous cholesterol and such 
effect appeared to be dose-dependent (Fig. 5B). 
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Finally, the transport of L-carnitine was stimulated by 
a potassium diffusion membrane potential induced in 
the presence of valinomycin (Fig. 5C). Taken 
together, the data indicate that cholesterol stimulated 
OCTN2 transport activity in proteoliposomes as well, 
and that the stimulatory effect on L-carnitine uptake 
was the result of the interaction with the OCTN2 
protein and not a secondary effect of the Na+/K+ 
pump. 
 
Effect of cholesterol content on OCTN2-mediated 
influx kinetics of L-carnitine 
To understand the nature of cholesterol-dependent 
stimulation of OCTN2-mediated L-carnitine 
transport, the influx kinetics of L-carnitine was 
measured in OCTN2-HEK293 cells after 20-minute 
pre-incubation with mcd at the extracellular 
concentration of 2.5 mM. Cholesterol depletion 
increased the Km of OCTN2 for L-carnitine (19.9 ± 
7.79 vs 76.9 ± 26.5 µM, P=0.02) with a slight, albeit 
significant, stimulation of the maximal capacity of 
the transport (0.63 ± 0.13 vs 0.92 ± 0.12 pmol/µg of 
protein/min, P=0.04) (Fig. 6A). Although the kinetic 
values obtained from the Hanes-Woolf 
transformation (Fig. 6B) were comparable to those 
calculated from the hyperbola derived from the 
Michaelis-Menten equation, it is noteworthy that in 
the latter, the influx Km for L-carnitine upon 
treatment with mcd might be overestimated as 
saturation of the transport reaction could not be 
reached. Kinetic parameters of L-carnitine transport 
mediated by OCTN2 are summarized in table 1. To 
understand whether the maximal capacity 
augmentation upon cholesterol depletion was 
because of an increased affinity for the Na+, L-
carnitine influx was measured at increasing 
extracellular concentrations of Na+. Figure 6C shows 
that the regression lines of the L-carnitine influx as a 
function of the extracellular concentration of Na+ in 
control and mβcd-treated cells nearly intersected on 
the x-axis, indicating comparable Km for the Na
+ 
(3.60 ± 0.26 vs 5.13 ± 0.70 mM, P=NS). Kinetic 
analysis in proteoliposomes showed that upon 
cholesterol insertion the Vmax increased in a dose-
dependent manner with no changes in the affinity 
towards L-carnitine. The Vmax of L-carnitine influx in 
the presence of 25% cholesterol (25µg 
cholesterol/mg of lipids) was higher than that in 
control proteoliposomes (6.15 ± 1.34 vs 2.47 ± 0.3 
pmol/µg of protein/min, P=0.0003) (Fig. 7A and B, 
table 1). To understand whether the effect of 
cholesterol insertion on the Vmax was secondary to a 
change in the affinity for the binding of Na+ to 
OCTN2, the influx of L-carnitine was measured in 
reconstituted proteoliposomes titrating the 
concentration of Na+ in the transport buffer. It can be 
seen that in cholesterol-loaded proteoliposomes the 
affinity for Na+ was ~ 4 times stronger than that in 
control proteoliposomes (P=0.03), suggesting that the 
cholesterol loading did change the affinity of OCTN2 




OCTN2 transports L-carnitine in a Na+-dependent 
manner with the binding to the Na+ and its inward 
gradient across the plasma membrane dictating the 
cycling of the protein and, in turn, the transport 
capacity (7,14). Here, we show that the transport of 
L-carnitine mediated by the human OCTN2 is 
markedly stimulated by the presence of cholesterol in 
the plasma membrane. In both the experimental 
models employed OCTN2-HEK293 cells and 
proteoliposomes harboring OCTN2, cholesterol 
stimulates the catalytic efficiency, calculated as the 
ratio between the Vmax and the Km, of OCTN2-
mediated L-carnitine uptake by ~ 3fold. Yet, the 
nature of the stimulatory effect varies depending on 
the experimental model used. When cholesterol is 
partially removed from living cells, the affinity of 
OCTN2 for L-carnitine falls, whereas the binding 
affinity to the Na+ does not change. When cholesterol 
is added to proteoliposomes harboring OCTN2 
extracted from OCTN2-HEK293 cells, the 
stimulation is strictly dependent on the enhanced 
binding of OCTN2 to the Na+. It is possible that the 
reduced affinity for L-carnitine upon depletion of 
cholesterol measured in intact HEK293 cells, but not 
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in proteoliposomes is the result of the disruption of 
heterogeneous tertiary complexes of OCTN2-
cholesterol-phospholipids that might be 
underrepresented in the liposomes, which are 
essentially constituted of phosphatidylcholine. 
Though sparse, studies demonstrated that each 
phospholipid exhibits unique changes in enthalpy, 
transition temperature and cooperativity within the 
membrane with progressive increases in cholesterol 
content (47-49). It is also interesting to notice that in 
HEK293 cells, OCTN2 does not localize in 
cholesterol/sphingolipid microdomains (lipid rafts), 
suggesting that, in this particular setting, the loss of 
integrity of the lipid rafts upon the treatment with 
mβcd may not play a role in the loss of affinity of 
OCTN2 for L-carnitine. These results clash with 
previous findings describing that in rat astrocytes 
Octn2 localizes primarily in lipid rafts upon 
activation of the protein kinase C (PKC) (40). It 
seems plausible that the cascade induced by PKC 
activation is important not only for the trafficking of 
OCTN2 to the membrane but also for its spatial 
organization between raft and non-raft domains. 
 
Although cholesterol depletion from OCTN2-
HEK293 cells does not affect the binding of Na+ to 
the carrier, a slight increase in the L-carnitine 
transport capacity of OCTN2 can be noticed, 
suggesting that the cholesterol depletion might still 
alter the inward Na+ gradient across the plasma 
membrane. Indeed, when compared to control cells, 
cholesterol-depleted cells are characterized by a 
plasma membrane hyperpolarization, which is 
consistent with a greater inward Na+ gradient 
resulting perhaps from an enhanced activity of the 
Na+-K+ ATPase. The dependence of the Na+-K+ 
ATPase enzyme on membrane cholesterol level is 
highly controversial with biphasic, stimulatory or 
inhibitory effects observed, depending on the 
experimental model employed (50-57), and on the 
method used for the cholesterol depletion (58-60). 
Whatever the effect is, it is likely to reflect the 
balance between (i) the direct impact of the 
cholesterol depletion on the enzymatic activity and (ii) 
the secondary effects ascribable to the increased 
membrane permeability to ions such as proton and 
Na+, upon cholesterol depletion (61). 
 
Plasma membrane cholesterol has been shown to 
have a biphasic effect on transporters’ activity. 
Examples are the Na+-K+ ATPase and the amino acid 
transporter ASCT2. In human red blood cells, the 
Na+-K+ ATPase activity is stimulated by a 5-25% 
reduction in the cholesterol level, but inhibited by a 
35-50% depletion (50). In a similar vein, the amino 
acid transporter ASCT2 has an optimum of activity in 
7.5%-cholesterol proteoliposomes, however, at 
higher contents of cholesterol, the transport activity 
is inhibited (62). Such biphasic response supports the 
idea of an 'optimum' membrane cholesterol for 
maximal activity of these membrane transport 
systems. This does not appear to be the case for 
OCTN2. The effect of cholesterol on the influx rate 
of L-carnitine in proteoliposomes is dose-dependent 
across the range of cholesterol content employed, 
very much like in the case of the organic cation 
transporter novel 1 (OCTN1), whose activity is 
stimulated by cholesteryl hemisuccinate in a dose-
dependent manner solely through an increase of the 
transport capacity (63). Cholesterol has been shown 
to alter also the transport activity of rat Oct1 and 
human OCT2 in yet another way. Cell-free-expressed 
rat Oct1 reconstituted in nanodiscs or 
proteoliposomes displays the allosteric high-affinity 
binding site only in the context of certain lipid 
microenvironment (e.g. the presence of cholesterol) 
(64). Analogously, the allosterism of the human 
OCT2 is abolished when cholesterol is removed from 
the cells (38).   
 
Elevated cellular cholesterol levels have been found 
in erythrocytes, adipocytes and skeletal muscle cells 
of animals fed a high fat diet (24-26), in aging tissues 
(65-69) and within the context of several acute and 
chronic disorders including acute kidney injury (70), 
liver disease (71) and Alzheimer’s (72). It has been 
suggested that the raising of plasma membrane 
cholesterol level represents a protective mechanism 
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that the cell employs under acute or chronic stress 
(73,74). Because of the critical role of OCTN2 in L-
carnitine uptake in most tissues (75), it is plausible 
that such elevation in cellular cholesterol might be 
coupled to a greater intracellular accumulation of L-
carnitine, which can exert multiple protective effect. 
By increasing the rate of β-oxidation of medium- and 
long-chain fatty acids, L-carnitine can buffer the 
harmful effect of lipid accumulation, which, when 
coupled to oxidative stress, leads to lipid peroxidation, 
cell death, inflammation and fibrosis (1,76-78). 
Moreover, L-carnitine can directly prevent the 
opening of the mitochondrial transition pore (79,80), 
which leads to mitochondrial depolarization, 
inhibition of cellular respiration, ATP depletion and 






Dulbecco's Modified Eagle Medium (DMEM), 
RPMI 1640 medium, penicillin/streptomycin and 
Geneticin G-418 were purchased from ThermoFisher 
Scientific (Waltham, MA). Biowest fetal bovine 
serum (FBS) was provided by VWR (Dietikon, CH). 
Poly-D-lysine was purchased from Corning (Bedford, 
MA). L-[methyl-3H]carnitine hydrochloride ([3H]L-
carnitine, specific activity: 81.0 Ci/mmol) and 
36Chloride (specific activity: 10 mCi/g) were 
synthesized by Amersham Life Sciences (Piscataway, 
NJ), [4-14C]-cholesterol ([14C]cholesterol, specific 
activity: 50.8 mCi/mmol) was purchased from 
PerkinElmer (Boston, MA). Non-labeled L-carnitine, 
methyl-β-cyclodextrin (mβcd) and non-labeled 
cholesterol were provided by Sigma-Aldrich 
(St.Louis, MO). Cholesterol-saturated mβcd 




HEK293 cells stably transfected with the coding 
sequence of human OCTN2 (OCTN2-HEK293) were 
previously characterized (14,82). Cells were 
maintained in DMEM supplemented with 10% FBS, 
100 units/ml penicillin, 100 μg/ml streptomycin, with 
Geneticin G-418 at concentration of 600 μg/ml. 
Human hepatocellular carcinoma cells (Huh-7) were 
grown in RPMI 1640 medium supplemented with 10% 
FBS, 100 units/ml penicillin and 100 μg/ml 
streptomycin.  
 
Transient transfection of Huh-7 cells 
For lipid extraction and transport assay, 3 × 105 cells 
were seeded onto 6-well plate and 3.5-cm dishes, 
respectively. After two days, cells were transfected 
with pcDNA3.1(+) plasmid containing the coding 
sequence of the human OCTN2 (2 μg/well) with 3% 
Lipofectamine 2000 (Invitrogen, Carlsbad, CA) in 
serum-free and antibiotic-free medium. Experiments 
were performed two days after transfection. 
 
OCTN2 reconstitution in proteoliposomes   
HEK293 cells with stable overexpression of OCTN2 
were harvested and resuspended in lysis buffer 
containing 1% (w/v) Triton-100, 20 mM 
Hepes/NaOH pH 7.5 and protease inhibitors. After 
incubation on ice for 30 minutes, the lysate was 
centrifuged at 12,000gav for 15 minutes at 4 °C. The 
supernatant was reconstituted by removing the 
detergent from mixed micelles containing detergent, 
protein and phospholipids. The composition of the 
initial mixture was: 100 μg of total proteins, 75 μl of 
10% Triton X-100, 110 μl of 10% egg yolk 
phospholipids in the form of sonicated liposomes and 
20 mM Hepes (pH 7.5) in a final volume of 700 μl. 
The detergent was removed by incubating the mixture 
with 0.55 g Amberlite XAD-4 for 60 minutes under 
stirring at 22 °C (83). 
 
Assessment of plasma membrane integrity  
OCTN2-HEK293 cells were seeded onto 6-well 
plates coated with 0.1 mg/ml poly-D-lysine at a 
density of 3 x 105 cells/well. After 72h, the cells were 
washed with phosphate buffer solution (PBS) and 
then treated for 20 minutes at 37°C with mβcd 
dissolved in Na+-containing transport buffer (116.4 
mM NaCl, 5.3 mM KCl, 1 mM NaH2PO4, 0.8 mM 
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MgSO4, 5.5 mM D-glucose and 20 mM Hepes/KOH, 
pH 7.4). Finally, cells were washed with PBS and 
resuspended in a 0.02% Trypan Blue solution for cell 
counting.  
 
Uptake assay in intact cells 
OCTN2-HEK293 cells were seeded onto 3.5-cm 
dishes coated with 0.1 mg/ml poly-D-lysine at the 
density of 3 x 105 cells/well. After 72 hours, cells 
were washed twice with Na+-containing transport 
buffer. Cells were exposed to Na+-containing 
transport buffer spiked with [3H]L-carnitine or 
36chloride. Uptake was stopped by quick aspiration 
and extensive washing with ice-cold Na+-containing 
transport buffer. Cells were solubilized with 1 ml of 
1% (w/v) Triton X-100 solution. Five hundred µl of 
the lysate were transferred in scintillation vials to 
assess the intracellular radioactivity. A 25 µl-aliquot 
was used for protein determination by the 
bicinchoninic acid (BCA) protein assay (Interchim, 
Montluçon Cedex, France). For determination of 
OCTN2-independent uptake of L-carnitine, the 
uptake was measured in Na+-free transport buffer, in 
which the Na+ was replaced with the monocation 
choline. This value was subtracted from the uptake in 
Na+-containing transport buffer to determine the L-
carnitine OCTN2-mediated transport. The uptake of 
L-carnitine in Na+-free transport buffer accounts for 
~15% of the uptake in transport buffer containing Na+. 
The uptake of L-carnitine in OCTN2-Huh-7 cells was 
assessed 48 hours after transfection. In this case, the 
uptake of L-carnitine in Na+-free transport buffer 
accounts for ~70% of the uptake in Na+-containing 
buffer. 
 
Uptake assay in proteoliposomes 
A 550 μl-aliquot of proteoliposomes was filtered 
through a Sephadex G-75 column (0.7 cm diameter × 
15 cm height). One hundred 100 μl-aliquotes of 
eluate were transferred to reaction vessels and used 
for transport measurement. Uptake assay was 
performed at 25°C and started by adding 50 μM L-
carnitine spiked with [3H]L-carnitine to 
proteoliposomes. The transport was stopped washing 
the proteoliposomes by chromatography using pirces 
columns (0.6 cm diameter × 8 cm height) containing 
Sephadex G-75. Intraliposomal radioactivity was 
measured as previously reported (83).  
 
Lipid extraction 
Lipid extraction was performed with a standard 
chloroform/methanol method (84). Cells were seeded 
at a density of 3 x 105 cells/well onto 6-well plate 
coated with 0.1 mg/ml poly-D-lysine. After 72 hours, 
cells were harvested and resuspended in 1 ml of PBS 
in glass tubes. One hundred μl were lysed with 400 μl 
of 1% (w/v) Triton X-100 for BCA protein 
determination. The remaining cell suspension was 
mixed with 3 ml of chloroform:methanol (2:1) 
solution spiked with [14C]cholesterol, serving as 
internal standard. After 20 minutes in shaking, 
samples were centrifuged for 5 minutes at 1500gav for 
phase separation. Upper phase and interphase were 
discarded and the lower phase containing the lipid 
fraction was dried under a nitrogen flux at 30°C. 
Finally, the lipid pellet was resuspended in 300 μl of 
ice-cold chloroform. A 50 μl-aliquot was used for 
assessing radioactivity by liquid scintillation 
counting.  
 
Thin layer chromatography 
For the analysis of the cholesterol content, aliquots 
from the extracted lipids were loaded on HPTLC 
Silica gel 60 plates with a concentrating zone (Merck 
KGaA, Darmstadt, Germany) using an automated 
Camag TLC sampler ATS4 and separated by one-
dimensional thin layer chromatography (TLC). 
Cholesterol was resolved in 62.4% n-hexane, 18.3% 
n-heptane, 18.3% diethyl ether and 1% acetic acid. 
Staining was performed in 9.6% orthophosphoric 
acid (v/v) and 3% copper acetate (w/v), and then the 
plate was dried at 120-130°C for 30 minutes. Bands 
were scanned at 366 nm and absolute quantification 
performed from a serial dilution of cholesterol 
resolved in parallel. The values were then normalized 





Cell surface labelling  
OCTN2-HEK293 cells were seeded onto a 6-well-
plate coated with 0.1 mg/ml poly-D-lysine. After 72 
hours, cells were washed twice with PBS and 
incubated on ice with EZ-Link Sulfo-NHS-LC-biotin 
(ThermoFisher Scientific, Waltham, MA), dissolved 
in PBS at the final concentration of 1 mg/ml. After 
one-hour incubation, cells were washed twice with 
PBS and then incubated for 30 minutes with 
hypotonic buffer (0.5 mM Na2HPO4 and 0.1 mM 
EDTA at pH 7.0) containing protease inhibitors 
(Roche Diagnostics GmbH, Mannheim, Germany). 
Cells were harvested by centrifugation at 16000gav 
for 15 minutes at 4°C, rotated for 2 hours in 200 μl of 
lysis buffer (50 mM Tris base, 150 mM NaCl, 1% 
Nonidet P-40, 0.5% sodium deoxycholate, pH 7.4) 
containing protease inhibitors and then spun down at 
16000gav at 4°C for 15 minutes. A portion of the 
supernatant was used for total lysate analysis. The 
remaining portion was incubated with streptavidin-
agarose beads (50 μl/sample) (ThermoFisher 
Scientific, Waltham, MA) in rotation, overnight at 
4°C. To stop the incubation, the beads were washed 
twice in lysis buffer and twice in lysis buffer 
supplemented with 2% (w/v) SDS. After the final 
wash, the proteins bound to the beads were stripped 
by incubation at 95°C for 5 minutes in Laemmli 
buffer containing 1.5% (w/v) dithiothreitol (DTT). 
 
Isolation of detergent-resistant membranes 
OCTN2-HEK293 cells were seeded onto 6-well-
plates coated with 0.1 mg/ml poly-D-lysine. After 72 
hours, cells were washed twice with PBS and 
incubated on ice with EZ-Link Sulfo-NHS-LC-biotin 
(ThermoFisher Scientific, Waltham, MA), dissolved 
in PBS at the final concentration of 1 mg/ml. After 
one-hour incubation, cells were washed twice with 
PBS, harvested by centrifugation at 16000gav for 15 
minutes at 4°C and incubated on ice with 1% (w/v) 
Triton-X 100 in PBS containing protease inhibitors. 
After 15 minutes, the lysate was spun down at 
16000gav for 15 minutes at 4°C, the supernatant 
(soluble fraction) was collected and the pellet 
(insoluble fraction) was rotated for 2 hours in 200 μl 
of lysis buffer (50 mM Tris base, 150 mM NaCl, 1% 
Nonidet P-40, 0.5% sodium deoxycholate, pH 7.4) 
containing protease inhibitors. The biotinylated 
proteins were pulled down as described above.  
 
Immunoblotting 
Protein samples were loaded onto a 8% 
polyacrylamide gels. Proteins were transferred onto 
nitrocellulose membranes (GE HealthCare, 
Piscataway, NJ). The membranes were blocked with 
5% (w/v) non-fat dry milk in PBS supplemented with 
0.1% (w/v) Tween 20 (PBS-T) and incubated 
overnight at 4°C with anti-OCTN2 (NBP2-57222, 
Novusbio, Littleton, CO), followed by probing with 
a horseradish peroxidase-conjugated anti-rabbit IgG 
antibody (G21234, ThermoFisher Scientific, 
Waltham, MA). As a control, the sample blots were 
probed with anti-Na+/K+ ATPase (ab7671, Abcam, 
Cambridge, UK), anti-CAVEOLIN-1 (610060, BD 
biosciences, San Jose, CA) and anti-FLOTILLIN-1 
(610821, BD biosciences, San Jose, CA). Blots were 
developed with SuperSignal West Femto Maximum 
Sensitivity Substrate (ThermoFischer Scientific, 
Waltham, MA) and Fusion FX7 (Vilber Lourmat, 
Eberhardzell, Germany).  
 
Statistical Analysis 
Statistical comparisons were performed using 
GraphPad Prism (version 8.0 for Windows, GraphPad 
Software). Comparisons between two groups were 
performed with the two-tailed Student's unpaired t-
test. For multiple comparisons, one-way analysis of 
variance (one-way ANOVA) followed by Tukey’s 
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Table 1. Kinetic parameters of L-carnitine transport rate mediated by OCTN2. 


























25% cholesterol 131±34.2 8.68±3.86 
 
Km values are expressed in µM 









Figure 1. Cholesterol content and L-carnitine influx in cells overexpressing the human 
OCTN2. Representative image of total cellular cholesterol content resolved in a silica plate and 
quantification of total cholesterol from OCTN2-HEK293 cells (A) and OCTN2-Huh-7 cells (B) 
exposed for 20 minutes to methyl-β-cyclodextrin (mβcd) at the extracellular concentration of 
2.5 mM. Data represents the mean ± S.D. from three independent experiments. Fifteen-second 
uptake of L-carnitine at the extracellular concentration of 0.5 µM, in OCTN2-HEK293 cells (C) 
and OCTN2-Huh7 (D) cells after 20-minute preincubation with mβcd at the extracellular 
concentration of 2.5 mM. Fifteen-second uptake of L-carnitine at the extracellular 
concentration of 0.5 µM, in OCTN2-HEK293 cells in the presence of 2.5 mM mβcd (E). Uptake 
data were subtracted of the uptake values in Na+-free buffer and expressed as the mean ± S.D. 







Figure 2. Plasma membrane localization of OCTN2. Representative Western blot and 
relative quantification from three independent experiments of OCTN2 and Na+/K+ ATPase 
expression biotinylated at the cell surface of OCTN2-HEK293 cells exposed for 20 minutes to 
mβcd at the extracellular concentration of 2.5 mM. The indicated P-values were calculated from 
unpaired t-test comparisons (A). Representative Western blot and relative quantification of the 
insoluble fractions (rafts) from three independent experiments of OCTN2, Na+/K+ ATPase, 
CAVEOLIN-1 and FLOTILIN-1 expression biotinylated at the cell surface of OCTN2-HEK293 
cells exposed for 20 minutes to mβcd at the extracellular concentration of 2.5 mM. Na+/K+ 
ATPase is used as non-raft marker, CAVEOLIN-1 and FLOTILIN-1 as raft markers. The 






Figure 3. Membrane integrity and chloride distribution across the plasma membrane of 
OCTN2-HEK293 cells. Percentage of cells impermeable to Trypan Blue dye. Data represent 
the mean ± S.D. from five independent experiments (A). Intracellular chloride content as a 
function of the time in OCTN2-HEK293 cells after 20-minute preincubation with the indicated 
conditions. Results are expressed as the mean ± S.D. from three independent experiments (B). 
Multiple comparisons were performed using one-way ANOVA test followed by Tukey’s test. 







Figure 4. Cholesterol content and OCTN2-mediated carnitine influx after exposure to 
exogenous cholesterol. Representative image of total cellular cholesterol resolved in a silica 
plate and quantification from OCTN2-HEK293 cells treated for 20 minutes with the indicated 
conditions. Data represents the mean ± S.D. from three independent experiments (A). Fifteen-
second uptake of L-carnitine in OCTN2-HEK293 cells after 20-minute preincubation with 
mβcd or mβcd:RAMEB (3:1) mixture. Results were subtracted of the uptake values in Na+-free 
buffer and expressed as the mean ± S.D. from three independent experiments (B) The indicated 







Figure 5. L-carnitine uptake in proteoliposomes harboring the human OCTN2. One-
minute transport of 80 µM L-carnitine at increasing extracellular concentrations of Na+. Results 
are expressed as the mean ± S.D. from four independent experiments (A). One-minute transport 
of 80 µM L-carnitine in the presence of 60 mM Na+ in proteoliposomes containing the indicated 
nominal cholesterol:phospholipid ratio. Data represent the mean ± S.D. from four independent 
experiments (B). One-minute transport of 80 µM L-carnitine in the presence of 60 mM Na+ in 
proteoliposomes loaded with 25% cholesterol and treated with valinomycin. Data represent the 
mean ± S.D. from three independent experiments (C). Multiple comparisons were performed 
using one-way ANOVA test followed by Tukey’s test. Significant differences between the 
means of two groups were calculated from unpaired t-test comparisons. 





Figure 6. Kinetic analysis of L-carnitine influx in intact cells. Initial uptake of L-carnitine 
was assessed in OCTN2-HEK293 cells at increasing extracellular concentrations of L-carnitine 
(A, B) or Na+ (C), after 20-minute preincubation with mβcd at the extracellular concentration 
of 2.5 mM . Data were corrected for uptake in Na+-free buffer and expressed as the mean ± S.D. 
from at least three independent experiments. The line is best-fit to the Michaelis-Menten 





Figure 7. Kinetic analysis of L-carnitine influx in proteoliposomes. Initial uptake of L-
carnitine was assessed in proteoliposomes harbouring the human OCTN2 at increasing 
extracellular concentrations of L-carnitine (A, B) or Na+ (C). Data were corrected for uptake in 
Na+-free buffer and expressed as the mean ± S.D. from at least three independent experiments. 
The line is best-fit to the Michaelis-Menten equation (V = Vmax[S]/(Km + [S])) (A). A Hanes-
Woolf (B) and a Hill (C) plot of the data.  
 
 
